| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 54 |
| 1 | OCRELIZUMAB | 54 |
| 2 | DIMETHYL FUMARATE | 52 |
| 3 | RITUXIMAB | 44 |
| 4 | DALFAMPRIDINE | 38 |
| 5 | PREDNISONE | 37 |
| 6 | ALEMTUZUMAB | 36 |
| 7 | CYCLOPHOSPHAMIDE | 30 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 30 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBALIZUMAB | 8 | 0.0148 |
| 1 | FOSTEMSAVIR TROMETHAMINE | 3 | 0.0123 |
| 2 | CIDOFOVIR ANHYDROUS | 9 | 0.0062 |
| 3 | DEFEROXAMINE MESYLATE | 10 | 0.0046 |
| 4 | LETERMOVIR | 14 | 0.0043 |
| 5 | MARIBAVIR | 10 | 0.0041 |
| 6 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 7 | 0.0040 |
| 7 | TREOSULFAN | 10 | 0.0036 |
| 8 | ALEMTUZUMAB | 36 | 0.0019 |
| 9 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 14 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD4-directed Blocking Antibody [EPC] | 8 | 0.0148 |
| 1 | Lead Chelator [EPC] | 1 | 0.0119 |
| 2 | CD19-directed Cytolytic Antibody [EPC] | 6 | 0.0070 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 14 | 0.0043 |
| 4 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 10 | 0.0041 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 36 | 0.0019 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 8 | Human Immunoglobulin G [EPC] | 17 | 0.0008 |
| 9 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |